urothelial bladder cancer
Showing 1 - 4 of 4
Urothelial Bladder Cancer, Triple-negative Breast Cancer, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (Tremelimumab
Active, not recruiting
- Urothelial Bladder Cancer
- +2 more
- Tremelimumab monotherapy
- +2 more
-
San Francisco, California
- +13 more
Jan 20, 2023
Intermediate and High-Risk Bladder Cancer Patients
Recruiting
- Urothelial Bladder Cancer
- CxBladder Monitor
-
White River Junction, Vermont
- +1 more
Sep 12, 2022
Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer Trial in Worldwide (Infigratinib, Placebo)
Recruiting
- Upper Tract Urothelial Carcinomas
- Urothelial Bladder Cancer
- Infigratinib
- Placebo
-
Tucson, Arizona
- +133 more
Apr 25, 2022
Urothelial Bladder Cancer, Gastric Adenocarcinoma, Gastro-oesophageal Adenocarcinoma Trial (Dostarlimab, Niraparib)
Not yet recruiting
- Urothelial Bladder Cancer
- +6 more
- (no location specified)
Feb 26, 2021